Laboratory-scale production of 13C-labeled lycopene and phytoene by bioengineered Escherichia coli.
Laboratory-scale production of 13C-labeled lycopene and phytoene by bioengineered Escherichia coli.
复制标题
通过生物工程大肠杆菌在实验室规模生产 13C 标记的番茄红素和八氢番茄红素。
DOI:
10.1021/jf202599z
复制
发表时间:
2011
影响因子:
6.1
通讯作者:
ErdmanJr,JohnW
中科院分区:
文献类型:
--
作者:
Lu,Chi-Hua;Choi,Jin-Ho;EngelmannMoran,Nancy;Jin,Yong-Su;ErdmanJr,JohnW
Consumption of tomato products has been associated with decreased risks of chronic diseases such as cardiovascular disease and cancer, and therefore the biological functions of tomato carotenoids such as lycopene, phytoene, and phytofluene are being investigated. To study the absorption, distribution, metabolism, and excretion of these carotenoids, a bioengineered Escherichia coli model was evaluated for laboratory-scale production of stable isotope-labeled carotenoids. Carotenoid biosynthetic genes from Enterobacter agglomerans were introduced into the BL21Star(DE3) strain to yield lycopene. Over 96% of accumulated lycopene was in theall-transform, and the molecules were highly enriched with13C by13C-glucose dosing. In addition, error-prone PCR was used to disrupt phytoene desaturase (crtI) function and create a phytoene-accumulating strain, which was also found to maintain the transcription of phytoene synthase (crtB). Phytoene molecules were also highly enriched with13C when the13C-glucose was the only carbon source. The development of this production model will provide carotenoid researchers a source of labeled tracer materials to further investigate the metabolism and biological functions of these carotenoids.